Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 73-84 of 4,306
Drug study icon
RecruitingNCT07459647

A Long-Term Study of ML-007C-MA in Adults With Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
MapLight Therapeutics
Condition
Schizophrenia
Drug study icon
RecruitingNCT07423546

A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In New York
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
Drug study icon
RecruitingNCT07410507

Brenipatide in adults with Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Argentina, in Brazil, ...

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States, Argentina, Brazil, ...
Sponsor
Eli Lilly and Company
Condition
Schizophrenia
Drug study icon
RecruitingNCT07145918

Adverse Events, Change for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
AbbVie
Condition
Schizophrenia
Drug study icon
RecruitingNCT07288567

KarXT for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Colombia, in Japan, ...

Multiple locations, including Anaheim
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 13 Years to 17 Years
Countries
United States, Colombia, Japan, ...
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
Drug study icon
RecruitingNCT06882785

KarXT for schizophrenia

The registry lists this study as recruiting. Study locations are listed in Japan.

Multiple locations, including Kōnan
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Japan
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
Drug study icon
RecruitingNCT07424404

KarXT and KarX-EC for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in France, ...

Multiple locations, including Anaheim
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 5 Years to 17 Years
Countries
United States, Australia, France, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT07061288

Safety, Tolerability, and PK of an Injectable Form of KarXT

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Los Alamitos
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
Drug study icon
RecruitingNCT06894212

SEP-363856 for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States and in Japan.

Multiple locations, including Konan-shi
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Japan
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.